(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HEMOCONE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

HEMOCONE

ST13

US500000079404975

Class

5

Filing

79404975

Registration

7846641

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

04/03/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

08/09/2024

Registration date

07/01/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/01/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

CH

Examiner

GULIANO, ROBERT N

Law office

L50

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Straumann Holding AG

Representatives

Molly Buck Richard Richard Law Group

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Natural collagen for medical purposes for use in dentistry; pharmaceutical preparations for treatment and prevention of diseases related to bones and tissues; filling materials for teeth and dental casting material in the nature of dental impression materials; biological preparations for human medical purposes for the treatment of diseases related to bones and tissues and prevention of such diseases; chemical pharmaceutical preparations for the treatment and prevention of diseases related to bones and tissues

Publications

History of USPTO decisions and trademark events.

29 publications found

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

03/12/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

02/25/2026

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

02/25/2026

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/19/2026

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/29/2026

FIMP

FINAL DISPOSITION PROCESSED

01/29/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/25/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/01/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/12/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/12/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/12/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/01/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

07/01/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/13/2025

PUBO

PUBLISHED FOR OPPOSITION

05/13/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/07/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/14/2025

RFNT

REFUSAL PROCESSED BY IB

04/05/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/27/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/27/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/27/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

03/18/2025

RFRR

REFUSAL PROCESSED BY MPU

03/18/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

02/11/2025

CNRT

NON-FINAL ACTION WRITTEN

02/10/2025

DOCK

ASSIGNED TO EXAMINER

02/05/2025

MAFR

APPLICATION FILING RECEIPT MAILED

09/30/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/30/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/26/2024

Continuous trademark protection

Get notified about every new filing that threatens HEMOCONE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.